Etiology of specific molecular alterations in human malignancies

Cytogenetic and Genome Research

Volumn 118, Issue 2-4, 2007, Pages 277-283

  Vauhkonen, H ^a,b   Heino, S ^a   Myllykangas, S ^a   Lindholm, P M ^a   Savola, S ^a   Knuutila, S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER GENETICS; CANCER RESEARCH; CARCINOGENICITY; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DERMATOFIBROSARCOMA PROTUBERANS; DISSEMINATED INTRAVASCULAR CLOTTING; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; GLIOMA; HELICOBACTER PYLORI; HUMAN; LUNG CANCER; MESOTHELIOMA; MOLECULAR GENETICS; MYELODYSPLASTIC SYNDROME; NEUROBLASTOMA; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA; STOMACH CANCER; SYNOVIAL SARCOMA;

ASBESTOS; CARCINOGENS; CHROMATIN; DNA; HELICOBACTER PYLORI; HUMANS; NEOPLASMS;

HELICOBACTER PYLORI;

EID: 36248967153     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108311     Document Type: Review

References (55)

1. Ascoli V, Aalto Y, Carnovale-Scalzo C, Nardi F, Falzetti D, et al: DNA copy number changes in familial malignant mesothelioma. Cancer Genet Cytogenet 127:80-82 (2001).
2. Atiye J, Wolf M, Kaur S, Monni O, Böhling T, et al: Gene amplifications in osteosarcoma-CGH microarray analysis. Genes Chromosomes Cancer 42:158-163 (2005).
3. Ault JG, Cole RW, Jensen CG, Jensen LC, Bachert LA, et al: Behavior of crocidolite asbestos during mitosis in living vertebrate lung epithelial cells. Cancer Res 55:792-798 (1995).
4. Ban S, Cologne JB, Neriishi K: Effect of radiation and cigarette smoking on expression of FUdR-inducible common fragile sites in human peripheral lymphocytes. Mut Res 334:197-203 (1995).
5. Bartosiewicz M, Penn S, Buckpitt A: Applications of gene arrays in environmental toxicology: Fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene, and trichloroethylene. Envir Health Perspect 109:71-74 (2001).
6. Brennan C, Zhang Y, Leo C, Feng B, Cauwels C, et al: High-resolution global profiling of genomic alterations with long oligonucleotide microarray. Cancer Res 64:4744-4748 (2004).
7. Caron H, van Schaik B, van der Mee M, Baas F, Riggins G, et al: The human transcriptome map: Clustering of highly expressed genes in chromosomal domains. Science 291:1289-1292 (2001).
8. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, et al: Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumors. Nature 359:162-165 (1992).
9. Forozan F, Karhu R, Kononen J, Kallioniemi A, Kallioniemi OP: Genome screening by comparative genomic hybridization. Trends Genet 13:405-409 (1997).
10. Glover TW: Common fragile sites. Cancer Lett 232:4-12 (2006).
11. Graham DY: Helicobacter pylori infection is the primary cause of gastric cancer. J Gastroenterol 35 S12:90-97 (2000).
12. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100:57-70 (2000).
13. Haverkos HW: Viruses, chemicals and co-carcinogenesis. Oncogene 23:6492-6499 (2004).
14. Heidenblad M, Lindgren D, Veltman JA, Jonson T, Mahlamaki EH, et al: Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: Implications for the interpretation of genomic amplifications. Oncogene 24:1794-1801 (2005).
15. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, et al: Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62:6240-6245 (2002).
16. International Agency for Research on Cancer: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 64 (WHO, Lyon 1995).
17. Israeli O, Goldring-Aviram A, Rienstein S, Ben-Baruch G, Korach J, et al: In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer. Cancer Genet Cytogenet 160:35-42 (2005).
18. Jensen CG, Jensen LC, Rieder CL, Cole RW, Ault JG: Long crocidolite asbestos fibers cause polyploidy by sterically blocking cytokinesis. Carcinogenesis 17:2013-2021 (1996).
19. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, et al: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821 (1992).
20. Kjellberg L, Hallmans G, Ahren AM, Johansson R, Bergman F, et al: Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 82:1332-1338 (2000).
21. Knuutila S: Cytogenetics and molecular pathology in cancer diagnostics. Ann Med 36:162-171 (2004).
22. Knuutila S, Autio K, Aalto Y: Online access to CGH data of DNA sequence copy number changes. Am J Pathol 157:689 (2000).
23. Krismann M, Muller KM, Jaworska M, Johnen G: Molecular cytogenetic differences between histological subtypes of malignant mesotheliomas: DNA cytometry and comparative genomic hybridization of 90 cases. J Pathol 197:363-371 (2002).
24. Krummel KA, Roberts LR, Kawakami M, Glover TW, Smith DI: The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations. Genomics 69:37-46 (2000).
25. Kuwano A, Kajii T: Synergistic effect of aphidicolin and ethanol on the induction of common fragile sites. Hum Genet 75:75-78 (1987).
26. Lengauer C, Kinzler KW, Vogelstein B: Genetic instabilities in human cancers. Nature 396:643-649 (1998).
27. Manning CB, Cummins AB, Jung MW, Berlanger I, Timblin CR, et al: A mutant epidermal growth factor receptor targeted to lung epithelium inhibits asbestos-induced proliferation and proto-oncogene expression. Cancer Res 62:4169-4175 (2002).
28. Miller CT, Lin L, Casper AM, Lim J, Thomas DG, et al: Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene 25:409-418 (2005).
29. Mitelman F, Johansson B, Mertens F (eds): Mitelman Database of Chromosome Aberrations in Cancer, http://cgap.nci.nih.gov/Chromosomes/Mitelman (2005).
30. Monni O, Barlund M, Mousses S, Kononen J, Sauter G, et al: Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci USA 98:5711-5716 (2001).
31. Myllykangas S, Knuutila S: Manifestation, mechanisms and mysteries of gene amplifications. Cancer Lett 232:79-89 (2006).
32. Myllykangas S, Monni O, Nagy B, Rautelin H, Knuutila S: Helicobacter pylori infection activates FOS and stress-response genes and alters expression of genes in gastric cancer-specific loci. Genes Chromosomes Cancer 40:334-341 (2004).
33. Myllykangas S, Himberg J, Bohling T, Nagy B, Hollmen J, Knuutila S: DNA copy number amplification profiling of human neoplasms. Oncogene 25:7324-7332 (2006).
34. Nymark P, Wikman H, Ruosaari S, Hollmen J, Vanhala E, et al: Identification of specific gene copy number changes in asbestos-related lung cancer. Cancer Res 66:5737-5743 (2006).
35. Nystrom M, Knuutila S, Rapp UR, Keski-Oja J: MMC-E cells - origin and changes in karyotype accompanying malignant transformation. Cancer Genet Cytogenet 15:243-251 (1985).
36. Obst B, Wagner S, Sewing KF, Beil W: Helicobacter pylori causes DNA damage in gastric epithelial cells. Carcinogenesis 21:1111-1115 (2000).
37. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, et al: The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3; 8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597 (1996).
38. Pennie W, Pettit SD, Lord PG: Toxicogenomics in risk assessment: An overview of an HESI collaborative research program. Envir Health Perspect 112:417-419 (2004).
39. Pinkel D, Sewgraves R, Sudar D, Clark S, Poole I, et al: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207-211 (1998).
40. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergemenhikov A, et al: Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23:41-46 (1999).
41. Rao PN, Heerema NA, Palmer CG: Fragile sites induced by FUdR, caffeine, and aphidicolin. Their frequency, distribution, and analysis. Hum Genet 78:21-26 (1988).
42. Robinson BW, Musk AW, Lake RA: Malignant mesothelioma. Lancet 366:397-408 (2005).
43. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW: Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 93:10614-10619 (1996).
44. Selikoff I, Hammond E, Churg J: Asbestos exposure, smoking, and neoplasia. J Am Med Assoc 204:106-112 (1968).
45. Sincock A, Seabright M: Induction of chromosome changes in Chinese hamster cells by exposure to asbestos fibres. Nature 257:56-58 (1975).
46. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874 (2001).
47. Tonon G, Wong KK, Maulik G, Brennan C, Feng B, et al: High-resolution genomic profiles of human lung cancer. Proc Natl Acad Sci USA 102:9625-9630 (2005).
48. Vainio H, Boffetta P: Mechanisms of the combined effect of asbestos and smoking in the etiology of lung cancer. Scand J Work Environ Health 20:235-242 (1994).
49. van Grieken NC, Weiss MM, Meijer GA, Hermsen MA, Scholte GH, et al: Helicobacter pylori-related and -non-related gastric cancers do not differ with respect to chromosomal aberrations. J Pathology 192:301-306 (2000).
50. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536 (2002).
51. Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA: Environmental and chemical carcinogenesis. Semin Cancer Biol 14:473-486 (2004).
52. Wu MS, Chang MC, Huang SP, Tseng CC, Sheu JC, et al: Correlation of histologic subtypes and replication error phenotype with comparative genomic hybridization in gastric cancer. Genes Chromosomes Cancer 30:80-86 (2001).
53. Zanella CL, Posada J, Tritton TR, Mossman BT: Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor. Cancer Res 56:5334-5338 (1996).
54. Zielenska M, Marrano P, Thorner P, Pei J, Beheshti B, et al: High-resolution cDNA microarray CGH mapping of genomic imbalances in osteosarcoma using formalin-fixed paraffin-embedded tissue. Cytogenet Genome Res 107:77-82 (2004).
55. zur Hausen H: Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Instit 92:690-698 (2000).